Company page
Nurexone Biologic Inc
Nurexone Biologic Inc (Ticker: NRX) is a public company based in Canada with a market capitalization of approximately CAD 28.36 million. The company focuses on developing innovative biologic therapies. Nurexone aims to address unmet medical needs through its research and product development efforts.
- Ticker
- NRX:TSXV
- Asset type
- Stock
- Market cap
- $28.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD